Citations
Mayo Clinic
1285 citation(s) found for "O'Neil, J".
A phase 1/2 study to evaluate safety and efficacy of nivolumab plus brentuximab vedotin in patients with CD30-expressing relapsed/refractory non-Hodgkin lymphomas (NHLs).
Armand, Philippe , Shustov, Andrei R., Moskowitz, Alison J. , Josephson, Neil C. , Salles, Gilles , Masood, Aisha, Ansell, Stephen M. , Salles, Gilles A , Brody, Joshua , Barr, Paul M. , Kline, Justin Paul , Savage, Kerry J. , Kuruvilla, John , Zinzani, Pier Luigi
Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: TPS7576-TPS7576
Genetic heterogeneity and survival among pancreatic adenocarcinoma (PDAC) patients with positive family history.
Petersen, Gloria M. , Chaffee, Kari G. , Majithia, Neil , Allen, Brian, Singh, Nanda, Hartman, Anne‐Renee , Oberg, Ann L. , McWilliams, Robert R. , Kidd, John
Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 4108-4108
Phase 1b extension study of cancer stemness inhibitor BB608 (napabucasin) administered in combination with FOLFIRI +/- bevacizumab (Bev) in patients (pts) with advanced colorectal cancer (CRC).
O’Neil, Bert H. , Starodub, Alexander, Jonker, Derek J. , Edenfield, William J. , El‐Rayes, Bassel F. , Hálfdánarson, Þorvarður R. , Ramanathan, Ramesh K., Pitot, Henry C., Britten, Carolyn D., Adesunloye, Bamidele, Borodyansky, Laura, Li, Chiang, El-Rayes, Bassel F , Halfdanarson, Thorvardur R , Hubbard, Joleen M. , Grothey, Axel
Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 3564-3564
Safety and clinical activity of durvalumab in combination with tremelimumab in extensive disease small-cell lung cancer (ED-SCLC).
Cho, Daniel C. , Dowlati, Afshin , Chung, Ki Y. , Schneider, Bryan J. , Razak, Albiruni Ryan Abdul, Tsai, Frank , Balmanoukian, Ani Sarkis, Xiao, Feng , Angra, Natasha, Abdullah, Shaad E. , Mahipal, Amit , Chow, Warren , Segal, Neil Howard , Nemunaitis, John , Bazhenova, Lyudmila , Luke, Jason J.
Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 8517-8517
Self-stated and actual practice patterns of general medical oncologists (MO) regarding the use of predictive biomarkers to guide treatment for patients (pts) with chronic lymphocytic leukemia (CLL).
Escalón, Maricer P. , Wierda, William G. , LaCasce, Ann S. , Harwin, William N., Kelly, Gloria, Miller, K., Paley, Douglas, Nelson, Joe, Ziel, Kathryn, Love, Neil, Wierda, William G. , Jevremović, Dragan , Nelson, Joe
Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: e19510-e19510
A U.S.-based survey: The experiences of 1147 chronic lymphocytic leukemia (CLL) patients (pts).
Koffman, Brian , Dennison, Betsy, Kennard, Kaitlin, Byrd, John C. , Pagel, John M., Nabhan, Chadi , Brander, Danielle M. , Hill, Brian T. , Pinilla‐Ibarz, Javier , Cheson, Bruce D. , Choi, Michael Y. , Mato, Anthony R. , Byrd, John C. , Davids, Matthew S. , Kay, Neil E. , Siddiqi, Tanya , Stephens, Deborah M. , Rosen, Steven T. , Awan, Farrukh T. , Byrd, John C
Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 7532-7532
Rapid progression of disease following ibrutinib discontinuation in patients with chronic lymphocytic leukemia.
Hampel, Paul J. , Chaffee, Kari G. , Ding, Wei , Call, Timothy G. , Muchtar, Eli , Leis, José F., Chanan‐Khan, Asher , Bowen, Deborah A., Fonder, Amie , Schwager, Susan M., Shanafelt, Tait D. , Ding, Wei , Muchtar, E , Shanafelt, Tait D , Kenderian, Saad S. , Slager, Susan L. , Kay, Neil E. , Parikh, Sameer A.
Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 7525-7525
Distinct immune signatures in chronic lymphocytic leukemia (CLL) and Richter’s syndrome (RS).
Secreto, Charla, Call, Timothy G. , Leis, José F., Feldman, Andew L., Ansell, Stephen M. , He, Rong , Wang, Yucai , Sinha, Sutapa , Dong, Haidong , Parikh, Sameer A. , Rech, Karen L. , Kenderian, Saad S. , Kay, Neil E. , Ding, Wei
Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 7524-7524
Scrambler therapy for established chemotherapy-induced neuropathy: A randomized phase II trial.
Loprinzi, Charles L. , Majithia, Neil , Bendel, Markus A. , Beutler, Andreas S. , Strick, D. M., Tilburt, Jon C. , Le‐Rademacher, Jennifer , McMurray, Ryan P. , Lachance, Daniel Honore , Cheville, Andrea , Smith, Thomas J.
Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 10016-10016
Phase 1b/2 trial of cancer stemness inhibitor napabucasin (NAPA) + nab-paclitaxel (nPTX) and gemcitabine (Gem) in metastatic pancreatic adenocarcinoma (mPDAC).
Starodub, Alexander, El‐Rayes, Bassel F. , Shahda, Safi, O’Neil, Bert H. , Shaib, Walid L. , Hanna, Wahid T., Mikhail, Sameh , Neki, A., Chang, Yue , Dai, Xiaoshu, Li, Wei , Brooks, Emily , Oh, Cindy , Borodyansky, Laura, Li, Chiang, El-Rayes, Bassel F , Bekaii‐Saab, Tanios , Noonan, Anne M. , Brooks, Emily
Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 4110-4110